Suchergebnisse - "Dranitsaris, George"

PubPharm (317)

1

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor

enthalten in: Current oncology (Toronto, Ont.) | 2024

von Gordan, L. | Ray, D. | Ijioma, S. | +8

2

Diagnosis and management of systemic mastocytosis in a community hematology setting

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Dranitsaris, G. | Neuhalfen, H. | Peevyhouse, A. | +4

3

Fostamatinib or Thrombopoietic Receptor Agonists for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients : A Real-World Assessment of Safety, Effectiveness and Cost

enthalten in: Acta haematologica | 2023

von Dranitsaris, G. | Peevyhouse, A. | Wood, T. | +3

4

Therapeutic preference for Alzheimer's disease treatments : a discrete choice experiment with caregivers and neurologists

enthalten in: Alzheimer's research & therapy | 2023

von Dranitsaris, G. | Zhang, Q. | Mu, L. | +5

5

Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists

enthalten in: Alzheimer's research & therapy | 2023

von Dranitsaris, G. | Zhang, Q. | Mu, L. | +5

6

Treatment Preference for Alzheimer's Disease : A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors

enthalten in: Neurology and therapy | 2023

von Dranitsaris, G. | Zhang, Q. | Quill, A. | +5

7

Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors

enthalten in: Neurology and Therapy | 2022

von Dranitsaris, G. | Zhang, Q. | Quill, A. | +5

8

Treatment Preference for Alzheimer’s Disease: A Multicriteria Decision Analysis with Caregivers, Neurologists, and Payors

enthalten in: Neurology and Therapy | 2022

von Dranitsaris, G. | Zhang, Q. | Quill, A. | +5

9

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Lau, C. | Dranitsaris, G.

10

Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH)

enthalten in: Neuromuscular disorders : NMD | 2022

von Riazi, S. | Bersselaar, L. | Islander, G. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]